Opens in a new tab

Aesculap v Shanghai International Holding (CFI, 1 May 2025)

Date1 May 2025
CourtCFI
DivisionDüsseldorf (DE) Local Division
Type of actionGeneric Order
Registry referenceORD_20781/2025
PartiesShanghai International Holding Corporation GmbH (Europe) v. Aesculap AG

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

In the provisional measures proceedings brought by Aesculap against Shanghai International Holding Corporation (Europe) under EP 2 892 442 (UPC_CFI_213/2025), the Düsseldorf Local Division asked the Presidium of the Court of First Instance to assign a technically qualified judge to the panel (IPC fields A61B and B23B). The order confirms that such an addition is possible at the provisional measures stage where the patent’s validity is challenged.

Question

May the panel add a technically qualified judge at the provisional measures stage, although Rule 34 refers only to proceedings on the merits?

Decision

Yes. Provisional measures are in principle available only if the patent’s validity is sufficiently secure (Article 62(4) UPCA and Rule 211.2), which requires the panel to assess whether it is more likely than not that the patent is invalid. Although Rule 34 mentions the technical judge only for the main proceedings, the second sentence of Article 8(5) UPCA allows the panel to add one of its own motion, after hearing the parties, including in summary proceedings. The challenge to novelty and inventive step, and the likely counterclaim for revocation in the pending main action, made the addition useful. No party objected.

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts 8(5), 18(3) and 62(4)
Rules of Procedure
Rules 34 and 211.2
Case law cited
10x Genomics, Court of Appeal, 26 February 2024, Mammut Sports Group v Ortovox Sportartikel, Court of Appeal, 25 September 2024, Valeo v Magna, Düsseldorf Local Division, 31 October 2024 (UPC_CFI_347/2024), 10x Genomics v Curio Bioscience, Düsseldorf Local Division, 29 January 2024

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Written procedure (UPC), Court fees and costs (UPC).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Generic Order
Outcome (Dhenne Avocats summary)
La division demande au présidium d'adjoindre un juge qualifié sur le plan technique à la formation saisie de la demande de mesures provisoires, la validité du brevet étant contestée.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 2 892 442
Surgical, torque-transmitting instrument including associated tool
recorded proprietor: Aesculap AG
Mentioned in the analysis (role not qualified)
Also mentioned in 8 other decision(s): Aesculap v Shanghai Bojin Medical Instrument (CFI, 1 September 2026) · Aesculap v Shanghai Bojin Medical Instrument (CFI, 27 August 2026) · Aesculap v Shanghai Bojin Medical Instrument (CFI, 4 December 2025) · Aesculap v Shanghai International Holding Corporation (Europe) (CFI, 3 · Aesculap v Shanghai International Holding Corporation (Europe) (CFI, 1 · Aesculap v Shanghai International Holding (CFI, 23 June 2025) · Aesculap v Shanghai International (Eur) (CFI, 10 June 2025) · Aesculap v Shanghai Bojin Medical Instrument (CFI, 16 October 2026)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.